https://abcnews.go.com/Health/aborted-fetuses-vaccines/story?id=29005539
What Aborted Fetuses Have to Do With Vaccines
17 February 2015
A small but growing number of parents who object to vaccinating their children on religious grounds say they do so because many common vaccines are the product of cells that once belonged to aborted fetuses.
There is a grain of truth to this statement. But even religious leaders, including a future pope, have said that shouldn't deter parents from vaccinating their children.
Vaccine and Cell Line Science
Some childhood vaccines, including the one against rubella which is part of the MMR vaccine given to millions of children worldwide for measles, mumps and rubella is cultured in "WI-38 human diploid lung fibroblasts," according to the U.S. Food and Drug Administration's fact sheet on the vaccine's ingredients.
Merck, the vaccine's manufacturer, acknowledged that those cells were originally obtained from an electively aborted fetus. They were used to start a cell line, which is a cell multiplied over and over again to produce cells that are of a consistent genetic makeup. The WI-38 cell line is used as a culture to grow live viruses that are used in vaccines.
Vaccines Developed Using Human Cell Strains
"Merck, as well as other vaccine manufacturers, uses two well-established human cell lines to grow the virus for selected vaccines," Merck said in a statement to ABC News. "The FDA has approved the use of these cell lines for the production of these Merck vaccines."
Other common vaccines, including those for chicken pox, hepatitis and rabies, are also propagated in cells originating from legally aborted human fetuses, according to the FDA.
"These abortions, which occurred decades ago, were not undertaken with the intent of producing vaccines," said a spokeswoman for the U.S. Centers Disease Control and Prevention.
The original cells were obtained more than 50 years ago and have been maintained under strict federal guidelines by the American Type Culture Collection, according to Merck.